Back

Direct oral anticoagulation versus warfarin in atrial fibrillation: a nationwide cohort study of effectiveness and safety among frail patients

26 August 2023 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Stroke prediction and prevention in atrial fibrillation Stroke in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mr Peter Bronnum Nielsen

Aalborg University, Aalborg (Denmark)

7 More presentations in this session

Presentation thumbnail
Atrial fibrillation burden and timing of anticoagulation therapy in patients with screen-detected and clinically-diagnosed AF
Doctor W. Sun (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Validation of novel electrocardiographic classification for stroke prediction in patients with atrial fibrillation undergoing cardioversion
Doctor A. Relander (Turku, FI)
Abstract Slides Video
Presentation thumbnail
Lower dose direct oral anticoagulation and warfarin in atrial fibrillation. Ischemic stroke, intracranial hemorrhage and mortality in a nationwide registry study.
Doctor O. Halminen (Aalto, FI)
Abstract Slides Video
Presentation thumbnail
10-year trends in oral anticoagulation therapies and ischemic stroke among 157,583 patients with non-valvular atrial fibrillation
Doctor W. Sun (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Left atrial appendage morphology and mitral annular plane systolic excursion predict stroke in patients with atrial fibrillation and high thromboembolic risk.
Professor D. Blendea (Cluj Napoca, RO)
Abstract Slides Video

Access the full session

Session thumbnail
Stroke prediction and prevention in atrial fibrillation

The Event

Event poster

ESC Congress 2023

26 August 2023 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of oral anticoagulants in frail atrial fibrillation patients: a report from an observational registry of european patients
thumbnail
Congress Presentation
Discussant review - FRAIL-AF
thumbnail
Congress Presentation
The FRAIL-AF randomized controlled trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources